Adonidis Konkolewscysp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-09-15
Registered address
Orlika 15, 06-300 Przasnysz, Poland
Electronic delivery address
AE:PL-85658-49402-UCFTD-28

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed.

  • 2025not filed
  • 202430/06/2025
  • 202305/07/2024
  • 202206/07/2023
  • 202112/07/2022
  • 202011/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 4.61mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 415.02kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 4.20mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 3.50mMedianUSD 544.32kAverageUSD 1.76m

Public procurement

Adonidis Konkolewscy is the contractor in one public sector contract, worth USD 76.05.

SubjectAmount
Purchase of equipment for school first-aid kits
$76.05

National Health Fund (NFZ) contracts

Adonidis Konkolewscy has been an NFZ healthcare provider since 2024. In 2026 it is performing 2 contracts with a total value of USD 22.90k. All its contracts were worth USD 52.83k in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesmazowieckie2USD 22.90k

Ownership

Owner
Stanisław Dziakage 81
Beata Dziak Konkolewskaage 53
Bartosz Jerzy Konkolewskiage 52

Manner of representation

Each partner has the right to represent the company in all judicial and extrajudicial acts.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2001-08-09.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 3,866

Public aid

5 public aid cases recorded, with a total value of $140,806.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$660
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,884
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,567

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
DR ZdrowieS.A.
MagmaxS.A.
Adpharmasp. z o.o.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

FAQ

Last updated: 2026-07-09